Featured Cancer Videos |view more
Penn Medicine expert Marouf Hoteit discusses the diagnosis and treatment of hepatocellular carcinoma.
Experts at Penn Medicine discussion treatment updates, clinical trials, and the future of sarcoma care.
Specialists in pancreatic cancer care at Penn Medicine’s Abramson Cancer center discuss the multidisciplinary approach to pancreatic cancer treatments at Penn Medicine.
Vivek Naray, MD of Penn Medicine reviews how oncologists use and think about androgen deprivation therapy (ADT) in prostate cancer.
Featured Articles & Documents |view more
In short, cytokine storm involves an immune response that causes collateral damage, which may be greater than the immediate benefit of the immune response.
For the first time, researchers led by SU2C “Dream Team” show how CD40 agonist drives an immune response to hard-to-penetrate tumors
Penn Medicine News